Petmed Express Inc Declares Quarterly Dividend of $0.27 (NASDAQ:PETS)

Share on StockTwits

Petmed Express Inc (NASDAQ:PETS) announced a quarterly dividend on Monday, October 21st, Zacks reports. Investors of record on Monday, November 4th will be given a dividend of 0.27 per share on Friday, November 15th. This represents a $1.08 dividend on an annualized basis and a yield of 4.38%. The ex-dividend date of this dividend is Friday, November 1st.

Petmed Express stock opened at $24.65 on Thursday. The company’s fifty day moving average price is $19.78 and its 200 day moving average price is $18.18. Petmed Express has a 1 year low of $15.00 and a 1 year high of $30.22. The stock has a market capitalization of $510.02 million, a P/E ratio of 19.60 and a beta of 0.57.

Petmed Express (NASDAQ:PETS) last released its quarterly earnings results on Monday, October 21st. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.07. Petmed Express had a net margin of 9.62% and a return on equity of 20.45%. The firm had revenue of $69.94 million for the quarter, compared to analysts’ expectations of $69.65 million. During the same quarter last year, the company earned $0.52 EPS. The firm’s revenue for the quarter was down 2.0% compared to the same quarter last year.

A number of equities research analysts recently issued reports on the stock. TheStreet raised shares of Petmed Express from a “c” rating to a “b-” rating in a research note on Tuesday, October 22nd. BidaskClub raised shares of Petmed Express from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. ValuEngine raised shares of Petmed Express from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Craig Hallum lifted their price target on shares of Petmed Express from $15.00 to $20.00 and gave the company a “hold” rating in a research note on Thursday, October 17th.

In other Petmed Express news, Director Gian Fulgoni sold 12,000 shares of Petmed Express stock in a transaction on Wednesday, October 23rd. The shares were sold at an average price of $26.45, for a total transaction of $317,400.00. Following the sale, the director now owns 58,900 shares of the company’s stock, valued at approximately $1,557,905. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 4.00% of the company’s stock.

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Read More: Mutual funds are not immune from market timing

Dividend History for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Ardagh Group SA  to Issue Dividend of $0.14 on  November 29th
Ardagh Group SA to Issue Dividend of $0.14 on November 29th
Precision BioSciences  Trading Up 5.6%
Precision BioSciences Trading Up 5.6%
Trans World Entertainment  Trading Up 5.3%
Trans World Entertainment Trading Up 5.3%
Front Yard Residential Corp  Expected to Announce Earnings of $0.03 Per Share
Front Yard Residential Corp Expected to Announce Earnings of $0.03 Per Share
iFresh  Trading Down 6.5%
iFresh Trading Down 6.5%
Century Aluminum   Shares Down 5.6%
Century Aluminum Shares Down 5.6%


© 2006-2019 Ticker Report